Oruka Therapeutics (ORKA) Net Income towards Common Stockholders (QoQ) (2010 - 2024)
Oruka Therapeutics (ORKA) Net Income towards Common Stockholders (QoQ) (2010 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Oruka Therapeutics |
3.86 Bn |
3.47 Bn |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
-33.30% |
| Mar 31, 2024 |
-84.48% |
| Dec 31, 2023 |
23.53% |
| Sep 30, 2023 |
3.78% |
| Jun 30, 2023 |
-9.96% |
| Mar 31, 2023 |
-14.65% |
| Dec 31, 2022 |
49.68% |
| Sep 30, 2022 |
25.87% |
| Jun 30, 2022 |
3.82% |
| Mar 31, 2022 |
42.35% |
| Dec 31, 2021 |
-20.46% |
| Sep 30, 2021 |
2.52% |
| Jun 30, 2021 |
-17.90% |
| Mar 31, 2021 |
20.00% |
| Dec 31, 2020 |
-157.41% |
| Sep 30, 2020 |
-52.92% |
| Jun 30, 2020 |
1.36% |
| Mar 31, 2020 |
-7.67% |
| Dec 31, 2019 |
-6.06% |
| Sep 30, 2019 |
19.50% |
